Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agimexpharm Pharmaceutical Joint Stock Company is a Vietnamese pharmaceutical manufacturer established in 1981. The company specializes in the production and distribution of a wide range of generic drugs, herbal medicines, health supplements, and cosmetics. With two GMP-WHO certified factories, Agimexpharm offers over 300 licensed products, including treatments for cardiovascular diseases, osteoporosis, and infectious diseases. The company is listed on the UPCoM stock exchange under the symbol AGP and maintains a strong presence in the Vietnamese healthcare market through its extensive distribution network. Agimexpharm continues to focus on modernizing its production technology and expanding its product portfolio to meet the growing healthcare needs of the community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agimexpharm.